INR301
/ Imnewrun Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 23, 2022
INR301, A NOVEL SUPERIOR BLOOD-BRAIN BARRIER PENETRATING ANTI-PD-L1 ANTIBODY, IMPROVES AD PATHOLOGY VIA BLOCKADE OF PD-1/PD-L1 PATHWAY IN AD MOUSE
(ADPD 2023)
- "Conclusions INR301, a novel superior BBB-penetrating anti- PD-L1 antibody , could improve pathological manifestations and cognitive loss through immune regulation of the PD-1/PD-L1 axis in the brain . Therefore, INR3 0 1 could serve as a promising strategy for the treatment of AD."
Preclinical • Alzheimer's Disease • CNS Disorders • Cognitive Disorders
1 to 1
Of
1
Go to page
1